CCND1 and B-cell non-Hodgkin lymphoma: CCND1 expression levels are increased more than 500‐fold in malignant B cell lymphomas. The t(11; 14) (q13; q32) causes a superenhancer that should intrinsically regulate IGH expression to interact with the CCND1, ultimately leading to a significant increase in CCND1 expression levels.